Tuesday, February 12, 2013

• 4 Healthcare Stock Stories for Tuesday Wellnessat Wall St. Cheat Sheet (Tue, Feb 12)

Monday, February 11, 2013

• Synageva initiates dosing in Phase 3 Sebelipase Alfa trialtheflyonthewall.com (Mon, Feb 11)
• Synageva BioPharma™ Initiates Dosing in Phase 3 Trial of Sebelipase Alfa in Children and Adults with Late Onset LAL DeficiencyBusiness Wire (Mon, Feb 11)

Wednesday, February 6, 2013

• Synageva BioPharma™ to Present at the Leerink Swann Global Healthcare Conference 2013Business Wire (Wed, Feb 6)

Tuesday, February 5, 2013

• Baker Brothers Reports Stakes in InterMune and Repros Therapeuticsat Motley Fool (Tue, Feb 5)

Monday, February 4, 2013

• Synageva announces publication of sebelipase alfa studyat theflyonthewall.com (Mon, Feb 4)
• Hepatology Publishes 12-Week Phase I/II Extension Study Data of Sebelipase Alfa in Adults with Late Onset LAL DeficiencyBusiness Wire (Mon, Feb 4)

Thursday, January 31, 2013

• Insiders Are Crazy About These 5 Stocksat Motley Fool (Thu, Jan 31)

Wednesday, January 30, 2013

• Synageva BioPharma™ Highlights Data Presentations at the 9th Annual Lysosomal Disease Network (LDN) WORLD SymposiumBusiness Wire (Wed, Jan 30)

Thursday, January 24, 2013

• ARIAD prices $300M stock offering to support launch of leukemia drugat bizjournals.com (Thu, Jan 24)

Wednesday, January 23, 2013

• Synageva to move, expand Lexington HQat bizjournals.com (Wed, Jan 23)

Tuesday, January 22, 2013

• SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct FinanciaEDGAR Online (Tue, Jan 22)

Saturday, January 12, 2013

• Which Companies Are In Michael King's Oncology Wheelhouse?at Seeking Alpha (Sat, Jan 12)

Wednesday, January 9, 2013

• 5 Stocks Insiders are Scooping Upat TheStreet (Wed, Jan 9)
• Top Insider Trades: Purchases at Synageva BioPharma and Lucas Energyat Minyanville (Wed, Jan 9)
• Synageva BioPharma Announces Closing of Public Offering and Exercise of Option to Purchase Additional SharesBusiness Wire (Wed, Jan 9)

Friday, January 4, 2013

• SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Jan 4)
• Synageva's Upside Is Limited By An Outsized Valuationat Seeking Alpha (Fri, Jan 4)

Thursday, January 3, 2013

• Synageva BioPharma Announces Pricing of Public Offering of Common StockBusiness Wire (Thu, Jan 3)
• Analyst Moves: BIIB, GEVAat Forbes (Thu, Jan 3)
• Why Synageva Is Poised to Underperformat Motley Fool (Thu, Jan 3)
• Synageva BioPharma Announces $80 Million Proposed Public Offering of Common StockBusiness Wire (Thu, Jan 3)

Wednesday, January 2, 2013

• 3 Biotech Stocks to Avoid in 2013at Motley Fool (Wed, Jan 2)

Wednesday, December 19, 2012

• Synageva BioPharma™ to Present at the 31st Annual J.P. Morgan Healthcare ConferenceBusiness Wire (Wed, Dec 19)

Monday, December 17, 2012

• SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Other EventsEDGAR Online (Mon, Dec 17)

Add GEVA News to My Yahoo!